VISFATIN/PBEF IN BONE REMODELLING OF RHEUMATOID ARTHRITIS

被引：0
|
作者：
Krumbholz, G. [1 ]
Junker, S. [1 ]
Lehr, A. [2 ]
Rickert, M. [3 ]
Schett, G. [4 ]
Lange, U. [1 ]
Rehart, S. [2 ]
Mueller-Ladner, U. [1 ]
Neumann, E. [1 ]
机构：
[1] Univ Giessen, Dept Rheumatol & Internal Med, Kerckhoff Klin Bad Nauheim, Giessen, Germany
[2] Markus Hosp, Dept Orthoped & Trauma Surg, Frankfurt, Germany
[3] Univ Hosp Giessen & Marburg, Dept Orthoped & Orthoped Surg, Giessen, Germany
[4] Med Clin Rheumatol & Immunol 3, Erlangen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
10.1136/annrheumdis-2013-203222.18
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A64 / A64
页数：1
相关论文
共 50 条
  • [21] Visfatin/PBEF and Atherosclerosis-Related Diseases
    Filippatos, Theodosios D.
    Randeva, Harpal S.
    Derdemezis, Christos S.
    Elisaf, Moses S.
    Mikhailidis, Dimitri P.
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (01) : 12 - 28
  • [22] Visfatin/PBEF/Nannpt: a new cardiovascular target?
    Peiro, Concepcion
    Romacho, Tania
    Carraro, Raffaele
    Sanchez-Ferrer, Carlos F.
    [J]. FRONTIERS IN PHARMACOLOGY, 2010, 1
  • [23] Bone remodelling in inflammatory arthritis
    Goldring, Steven R.
    Purdue, P. Edward
    Crotti, Tania N.
    Shen, Zhenxin
    Flannery, Merrilee R.
    Binder, Nikolaus B.
    Ross, F. Patrick
    McHugh, Kevin P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 52 - 55
  • [24] Adipokin visfatin and its influence on inflammation in rheumatoid arthritis
    Meier, F. M. P.
    Knedla, A.
    Lefvre, S.
    Schaeffler, A.
    Buechler, C.
    Stuerz, H.
    Mueller-Ladner, U.
    Neumann, E.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 24 - 24
  • [25] Visfatin/PBEF signalling pathways in articular chondrocytes
    Madolaine, Gusset
    Berenbaum, Francis
    Salvat, Colette
    Sautet, Alain
    Pigenet, Audrey
    Jacques, Claire
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S656 - S656
  • [26] Visfatin and Rheumatoid Arthritis: Pathogenetic Implications and Clinical Utility
    Polyakova, Yulia, V
    Zavodovsky, Boris, V
    Sivordova, Larisa E.
    Akhverdyan, Yuri R.
    Zborovskaya, Irina A.
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2020, 16 (03) : 224 - 239
  • [27] Serum Visfatin Levels in Patients with Axial Spondyloarthitis and Early Rheumatoid Arthritis: Relation to Inflammation and Bone Changes
    Hulejova, Hana
    Prajzlerova, Klara
    Krystufkova, Olga
    Grobelna, Krystyna
    Filkova, Maria
    Mann, Herman F.
    Pavelka, Karel
    Vencovsky, Jiri
    Senolt, Ladislav
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [28] VISFATIN/NAMPT/PBEF: ROLE IN VASCULAR WALL INFLAMMATION
    Romacho, T.
    Azcutia, V
    Vazquez-Bella, M.
    Cercas, E.
    Ruiz, C.
    Villalobos, L.
    Palacios, E.
    Carraro, R.
    Sanchez-Ferrer, C. F.
    Peiro, C.
    [J]. HYPERTENSION, 2009, 54 (05) : 1169 - 1169
  • [29] Abnormal bone remodelling in inflammatory arthritis
    Bogoch, ER
    Moran, E
    [J]. CANADIAN JOURNAL OF SURGERY, 1998, 41 (04) : 264 - 271
  • [30] Visfatin/PBEF/Nampt的研究进展
    朱剑
    刘超
    [J]. 临床与病理杂志, 2007, (01) : 81 - 84
12345